How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Pharmaceutical Filtration Centrifuges Market
- By Centrifuge Type: Batch Centrifuges, Continuous Centrifuges, Disc Stack Centrifuges, Decanter Centrifuges, Tubular Bowl Centrifuges
- By Filtration Mechanism: Pressure Filtration, Vacuum Filtration, Centrifugal Filtration, Membrane Filtration, Depth Filtration
- By Application: Active Pharmaceutical Ingredient (API) Recovery, Biopharmaceutical Processing, Sterile Filtration, Vaccine Production, Antibiotic Production
- By End-User: Pharmaceutical Manufacturers, Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Research and Development Laboratories, Academic and Research Institutes
- By Material of Construction: Stainless Steel, Titanium, Plastic Polymers, Glass-Lined Steel, Ceramic
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Batch Centrifuges leads By Centrifuge Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.186 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.194 →
Full report · locked preview
Everything inside the Pharmaceutical Filtration Centrifuges Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Centrifuge Type 5
Filtration Mechanism 5
Application 5
End-User 5
Material of Construction 5
Companies profiled
GEA Group
Alfa Laval
SPX FLOW
Andritz AG
Bucher Industries
Sartorius AG
Pall Corporation (Danaher)
Praj Industries
Tetra Pak
Mitsubishi Kakoki Kaisha
Hosokawa Micron Group
Büchi Labortechnik AG
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →GEA Group
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Alfa Laval
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →SPX FLOW
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Andritz AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Bucher Industries
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Pall Corporation (Danaher)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Praj Industries
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Tetra Pak
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mitsubishi Kakoki Kaisha
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Hosokawa Micron Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Büchi Labortechnik AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Flottweg SE
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Westfalia Separator (GEA Group)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Kreyer GmbH
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,148M by 2033 · 9.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Batch Centrifuges48.0
- Continuous Centrifuges11.3
- Disc Stack Centrifuges9.9
- Decanter Centrifuges16.2
- Tubular Bowl Centrifuges14.7
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,621M → $3,177M · 8.8%
Europe$1,130M → $2,515M · 10.5%
Asia Pacific$1,032M → $2,143M · 9.6%
Latin America$638.6M → $1,233M · 8.6%
Middle East and Africa$491.2M → $947.9M · 8.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.452026
9.462027
9.472028
9.492029
9.492030
9.502031
9.522032
9.542033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- GEA Group20.3
- Alfa Laval17.7
- SPX FLOW8.0
- Andritz AG8.2
- Bucher Industries10.8
- Sartorius AG7.0
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Centrifuge Type19.6%
Filtration Mechanism10.5%
Application28.3%
End-User13.9%
Material of Construction27.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.7
- Europe25.1
- Asia Pacific21.4
- Latin America12.3
- Middle East and Africa9.5
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| GEA Group | 86 | 79 | 87 | 80 | 78 | 73 | 81 |
| Alfa Laval | 81 | 69 | 68 | 87 | 84 | 87 | 79 |
| SPX FLOW | 88 | 86 | 78 | 66 | 87 | 71 | 79 |
| Andritz AG | 80 | 58 | 62 | 75 | 66 | 76 | 70 |
| Bucher Industries | 69 | 72 | 65 | 71 | 58 | 73 | 68 |
| Sartorius AG | 57 | 49 | 66 | 62 | 58 | 50 | 57 |
| Pall Corporation (Danaher) | 45 | 64 | 51 | 63 | 50 | 58 | 55 |
| Praj Industries | 43 | 47 | 38 | 51 | 39 | 41 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- GEA Group
- Alfa Laval
- SPX FLOW
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| GEA Group | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Alfa Laval | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| SPX FLOW | ✓ | ✓ | ✓ | ◐ | ✓ | ◐ |
| Andritz AG | ✓ | − | ◐ | ✓ | ◐ | ✓ |
| Bucher Industries | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Sartorius AG | − | ◐ | ◐ | ◐ | − | − |
| Pall Corporation (Danaher) | ◐ | ◐ | ◐ | ◐ | − | ◐ |
| Praj Industries | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1GEA Group81
2Alfa Laval79
3SPX FLOW79
4Andritz AG70
5Bucher Industries68
6Sartorius AG57
7Pall Corporation (Danaher)55
8Praj Industries43
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
GEA GroupAlfa LavalSPX FLOW
Challenger2
Strong scale, closing on the leaders.
Andritz AGBucher Industries
Contender1
Focused players with pockets of strength.
Sartorius AG
Niche2
Specialists in a single segment or region.
Pall Corporation (Danaher)Praj Industries
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Centrifuge Type in North America, then scale across Pharmaceutical Filtration Centrifuges Market — a $557M beachhead inside a $11.0B market.
Beachhead (SOM)$557Mobtainable near-term
Serviceable (SAM)$3.84Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Batch Centrifuges
Best fit — highest urgency & budget in Centrifuge Type.
Economic buyer79 fit
Continuous Centrifuges
Strong fit — clear ROI and a fast path to value.
End user69 fit
Disc Stack Centrifuges
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Centrifuge Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Filtration Mechanism & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Centrifuge Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Pharmaceutical Filtration Centrifuges Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified22%
Evaluation12%
Closed-won7%
$17.4KCAC
$101KLTV
5.8:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Pharmaceutical Filtration Centrifuges Market is a resilient opportunity — $1.33B by 2033, compounding at 4.8%.
TAM · 2025$920Mtoday
TAM · 2033$1.33Bforecast
CAGR4.8%2027–2033
Cumulative$10.0Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.33BTotal addressable market
SAM$493MServiceable available market
SOM$79MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.8% CAGR
Demand compounds through 2033, outpacing GDP across Centrifuge Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Centrifuge Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.33BLarge & growingTAM by 2033 at 4.8% CAGR
$493MServiceable nowreachable with today’s model
$79MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.04BBear3.1% CAGR
$1.33BBase4.8% CAGR
$1.71BBull6.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Filtration Mechanism optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Pharmaceutical Filtration Centrifuges Market — a $6.61B market by 2033. Plan: grow share from 9.1% to 14.8%.
Market size · 2033$6.61Btotal addressable
Market CAGR9.9%2027–2033
Target share14.8%from 9.1% today
Revenue ambition$978Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.1% | 14.8% | On track |
| Revenue | $579M | $978M | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 32.0% | 41.8% | On track |
| Customer retention | 88.3% | 93.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Centrifuge Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Filtration Mechanism capability
A defensible second engine — invest in Filtration Mechanism to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Centrifuge Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Filtration Mechanism
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $99M capacity & capability investment
- Greenlight bolt-on M&A in Filtration Mechanism
- Authorise North America expansion plan
- Fund R&D program for Centrifuge Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAhead
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Pharmaceutical Filtration Centrifuges Market conversation — a $5.98B market you can size, segment and defend in minutes.
Market size · 2033$5.98Btotal opportunity
Growth6.7%CAGR to 2033
Addressable buyers1,610+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Centrifuge Type
Goal Grow share in Centrifuge Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$87K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
GEA GroupAlfa LavalSPX FLOWAndritz AGBucher IndustriesSartorius AGPall Corporation (Danaher)Praj Industries+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Pharmaceutical Filtration Centrifuges Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Pharmaceutical Filtration Centrifuges Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Pharmaceutical Filtration and Purification Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportPharmaceutical Filter Aid Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportPharmaceutical Film Coatings Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportPharmaceutical Film Coating Powder Market
Market size, share, segmentation and regional forecast.
$922M market · 2025 base year
View reportPharmaceutical Filling Systems Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportPharmaceutical Filling Needle Market
Market size, share, segmentation and regional forecast.
$1.2B market · 2025 base year
View reportPharmaceutical Filling Machine Market
Market size, share, segmentation and regional forecast.
$965M market · 2025 base year
View reportPharmaceutical Filling and Sealing Equipment Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportPharmaceutical Feeders Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportPharmaceutical Extrusion Equipment Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportPharmaceutical Extruder Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportPharmaceutical Excipients Malic Acid Market
Market size, share, segmentation and regional forecast.
$432M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.